Back to profiles

Dipesh A. Patel, Ph.D.

Dallas/Fort Worth Area

With over 13 years of experience in driving growth and hands-on advisory practice, Dr. Dipesh Patel has provided strategy, business development, research and analysis, innovation and due diligence services across healthcare sectors including biopharma/biotech, medtech, digital health and academia. He works with innovative healthcare and technology organizations on smart medical wearables/devices and Internet of Things strategy to explore innovative medicines/therapies, personalized care and decision-making solutions.

Request a Call

On-demand, expert advice.

Areas of Expertise

  • Executive/Strategy

    Developed market, business, product, customer and innovation strategies for clients with products including, cancer drugs, biosensors, and healthcare tech. Shaped strategic initiatives for leadership, medical, R&D and commercial teams by delivering tumor-specific reference tools, landscape assessments, competitor reports, clinical trial strategies, marketing content, and market insights

    • Business
    • Strategy
    • Bio sensory technology
    • Biopharma and medical device
    • Diagnostics
    • Big Data Analytics
    • Wearable devices
    • mHealth
    • Pharmaceuticals
    • Oncology
    • Disease Prevention
  • Business Development and Strategic Alliances

    Business development activities in cancer drug/device development, wearables and Internet of Things has cultivated a granular and high-level perspective of an evolving, interconnected healthcare ecosystem. Moreover, exposure in cutting-edge innovations from over 12 industries enables unique insight into the organic process of seeing opportunities ahead of the curve.

    • Business
    • Business development
    • Partnerships
    • Strategic alliances
    • Business development
    • Product development
    • business model innovation
    • product innovation
  • Life Science Research and Analysis

    Conducted business and technology due diligence activities and disseminated scientific, clinical and economic value information in medical applications including oncology, immunology, cardiology, and neurology to multi-disciplinary stakeholders. Additionally evaluated innovative wearable and Internet of Things technology and use cases in the context of healthcare innovation.

    • Research and Clinical
    • Clinical strategy
    • Imaging and imaging systems
    • Wearable devices
    • Clinical Decision Support
    • Clinical Research
    • Clinical Trial
    • Clinical Trial Design
    • Oncology
    • Biochemistry
    • Immunology
    • Cancer drugs
    • Medical Devices
    • Healthcare IT

My Interests

Health Sectors
Medical Devices, Digital Health, Biotech, Health IT, Healthcare Delivery, Pharmaceuticals, Diagnostics


  • Entrepreneur in Residence

    Rosellini Scientific LLC | June 2015 - Current

    At Rosellini Scientific, we invest both expertise and capital in the development of medical technology. We collaborate with leading researchers at pioneering universities and companies to turn ideas into innovations and ultimately into new companies. We support patients by preventing disease, restoring function and enhancing quality of life by deploying integrated disease management solutions that require active therapeutics and coordinated rehabilitation care. Our goal is to manage the medical devices designed to support patients in sub-acute healthcare settings. Where devices don't already exist, we invent them by developing solutions utilizing the interconnection of software, hardware, and biomedical implants. Our process involves incubating ideas using non-dilutive funding, lean Biodesign principles and trailblazing CEO’s Rosellini Scientific also specializes in the development and delivery of mobile, networked biomedical solutions. Our Dental Division offers mobile dental management and provides a single source for decisions concerning mobile healthcare delivery in dental, optometry, audiology, podiatry and physical therapy to nursing home administrators. The Rosellini Scientific team is currently working on new therapies for the treatment of atrial fibrillation, epilepsy, congestive heart failure, overactive bladder, speech and cognitive rehabilitation, tinnitus, stroke and cancer. Will Rosellini has founded 6 life sciences companies that have raised nearly $45M in funding. Two of these companies have exited returning nearly $60M to investors and 4 are in progress. The company is located in Texas and Belgium. The Rosellini Scientific network includes operating divisions in point of care medicine for dental and psychiatry and health technology management; Rosellini Scientific portfolio companies such as Microtransponder, Neurotek Medical, CardiaX and nUro are currently developing solutions for a host of neurological disorders.

  • Head of Business Development and Research

    Amyx+McKinsey | June 2015 - Current

    Amyx+McKinsey is a smart wearables and Internet of Things (IoT) strategy + innovation + execution agency. Wearables and the Internet of Things can be classified into the following concentric circles of connected networks: 1. Smart Body – Body area network (BAN) 2. Smart Life – Personal area network (home, car, work) 3. Smart World – Wireless sensor network (street, buildings, places) The Smart Body or the body area network (BAN), comprises wearables that are smart computing and sensor-laden devices worn on the body, inside the body or on our clothes. The Smart Life and Smart World, comprises the IoT, which connects consumer objects, cars, homes, cities, industrial equipment and buildings, and the physical environment to the network, enabling information gathering and sharing and the management of these Internet-enabled objects to increase efficiency, automation, cost savings, productivity and revenue, or achieve health, safety or environmental benefits. As a thought leader in wearables & IoT, Amyx+McKinsey has the creative horsepower and the development prowess to execute even the most complex client engagements. Our capabilities and service offerings include wearables & IoT strategy, innovation lab, accelerator creation, prototyping, sensor licensing, AI/ machine learning data analytics, manufacturing, global distribution and full-stack enterprise system development and system integrations. We employ a flexible methodology to fit the client and needs and objectives while adapting to changing wearables & IoT environments. We have presence in Silicon Valley, NYC, Seoul, Shanghai and Cyprus. Please visit for more information

  • Business Development and Strategic Partnerships

    Om Associates | September 2003 - Current